| 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer (NCT00308516) | SCRI Development Innovations, LLC | 2006-03-01 |
| Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia (NCT00335504) | National Cancer Institute (NCI) | 2006-03-01 |
| Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma (NCT00353457) | Abramson Cancer Center at Penn Medicine | 2006-02-01 |
| Volume-outcome Relationship in Rectal Cancer Surgery (NCT04761536) | University of Rome Tor Vergata | 2006-01-01 |
| Preoperative Downstaging of Extraperitoneal T3 Rectal Cancer: XELOXRT Versus XELACRT. A Multicenter, Phase III Study (NCT01653301) | Catholic University of the Sacred Heart | 2005-10-01 |
| Preoperative Chemoradiation With Capecitabine and Cetuximab (NCT00297128) | Austrian Breast & Colorectal Cancer Study Group | 2005-10-01 |
| Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer (NCT00254683) | University of Sao Paulo | 2005-09-01 |
| Oxaliplatin and 5-FU Based Preoperative Chemoradiation (NCT00278694) | Oslo University Hospital | 2005-09-01 |
| Promoting Physical Activity After Colorectal Cancer (NCT00230646) | The Miriam Hospital | 2005-07-01 |
| Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer (NCT00216086) | Gabi Chiorean, MD | 2005-05-01 |
| Clinical Trial in Patients With Metastatic Colorectal Cancer (NCT00235898) | Mast Therapeutics, Inc. | 2005-05-01 |
| Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer (NCT00835055) | St. Claraspital AG | 2005-04-01 |
| Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer (NCT00250835) | New Mexico Cancer Research Alliance | 2005-04-01 |
| A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer (NCT02694718) | Hoffmann-La Roche | 2005-03-01 |
| Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer (NCT00113230) | M.D. Anderson Cancer Center | 2005-02-01 |
| Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer (NCT00101894) | Amgen | 2004-12-01 |
| Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer (NCT00200200) | Memorial Sloan Kettering Cancer Center | 2004-11-19 |
| Hydralazine as a Demethylating Agent in Rectal Cancer (NCT00575640) | University of Arkansas | 2004-11-01 |
| Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma (NCT00297141) | Austrian Breast & Colorectal Cancer Study Group | 2004-10-01 |
| Molecular Genetic and Pathological Studies of Anal Tumors (NCT00267787) | Stanford University | 2004-09-01 |
| Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma (NCT00207831) | Institut Cancerologie de l'Ouest | 2004-07-01 |
| Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases (NCT00587964) | Memorial Sloan Kettering Cancer Center | 2004-06-01 |
| COLOR II: Laparoscopic Versus Open Rectal Cancer Removal (NCT00297791) | Nova Scotia Health Authority | 2004-06-01 |
| A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer (NCT00226941) | George Albert Fisher | 2004-06-01 |
| Clinical Trial in Patients With Metastatic Colorectal Cancer (NCT00081627) | Mast Therapeutics, Inc. | 2004-04-01 |
| Comparison of Preoperative and Postoperative Radiotherapy and Capecitabine in Locally Advanced Rectal Cancer (NCT01186081) | Asan Medical Center | 2004-03-01 |
| Comparative Study of Circular Stapling Instruments (NCT00399009) | Uppsala University Hospital | 2004-01-01 |
| Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer (NCT00532987) | Stanford University | 2003-12-01 |
| Evaluating The Response to Pre-Operative Chemotherapy and/or Radiation Therapy For Rectal Cancer Using Three-Dimension Transrectal Ultrasound (NCT00597610) | Memorial Sloan Kettering Cancer Center | 2003-11-01 |
| Preoperative Radiotherapy and Local Excision in Rectal Cancer (NCT00738790) | Polish Colorectal Cancer Study Group | 2003-11-01 |
| Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA (NCT00394615) | Stanford University | 2003-10-01 |
| Cellular Immune Augmentation in Colon and Rectal Cancer (NCT00257322) | University of California, Irvine | 2003-04-01 |
| Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer (NCT00094809) | Amgen | 2003-02-01 |
| Quality Initiative in Rectal Cancer (QIRC) Trial (NCT00182130) | Hamilton Health Sciences Corporation | 2002-05-01 |
| J-pouch Versus Side-to-end Coloanal Anastomosis After Preoperative Radiotherapy and Total Mesorectal Excision for Rectal Cancer (NCT00956241) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2002-04-01 |
| Capecitabine in the Perioperative Treatment of Rectal Cancer (NCT01500993) | Universitätsmedizin Mannheim | 2002-03-01 |
| Prospective Randomised Study Comparing Laparoscopic Versus Open Surgery in Patients With Rectal Cancer (NCT00782457) | Hospital Universitario Virgen de la Arrixaca | 2002-01-01 |
| Nurse-or Surgeon-led Follow-up After Rectal Cancer (NCT01045200) | Centrallasarettet Västerås | 2002-01-01 |
| A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer (NCT00122291) | Alberta Health services | 2002-01-01 |
| Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors (NCT00028405) | Light Sciences LLC | 2001-11-01 |
| A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer (NCT00220051) | Royal Marsden NHS Foundation Trust | 2001-11-01 |
| A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients (NCT00254436) | M.D. Anderson Cancer Center | 2001-10-31 |
| Sphincter-preserving Surgery After Preoperative Treatment of Ultra-low Rectal Carcinoma (NCT00979680) | Institut du Cancer de Montpellier - Val d'Aurelle | 2001-04-01 |
| Radiation Therapy With Capecitabine in Rectal Cancer (NCT00176787) | University of Michigan Rogel Cancer Center | 2000-10-01 |
| Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer (NCT00695201) | Memorial Sloan Kettering Cancer Center | 2000-08-01 |
| Vaccine Therapy in Treating Patients With Metastatic Cancer (NCT00020267) | National Cancer Institute (NCI) | 2000-07-01 |
| Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps (NCT00005094) | National Cancer Institute (NCI) | 2000-03-01 |
| Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer (NCT00041652) | Gilead Sciences | 2000-02-01 |
| A Randomized Controlled Clinical Trial Comparing Oncological Results and Functional Recovery Between Laparoscopic and Open Method for the Treatment of Advanced Rectal Cancer After Concurrent Chemoradiation Therapy (CCRT) (NCT00601549) | National Taiwan University Hospital | 2000-01-01 |
| Factors Predicting Recurrence in Rectal Cancer After Surgery (NCT03899870) | ammar houssem | 2000-01-01 |
| Rectal Cancer Trial On Defunctioning Stoma (NCT00636948) | Rectal Cancer Trial on Defunctioning Stoma Study Group | 1999-12-01 |
| Randomized Clinical Trial on Preoperative Radiotherapy 25 Gy in Rectal Cancer (NCT01444495) | Jagiellonian University | 1999-01-01 |
| Fistula-associated Anal Adenocarcinoma (NCT05381324) | Medical University of Vienna | 1999-01-01 |
| The Stockholm III Trial on Different Preoperative Radiotherapy Regimens in Rectal Cancer (NCT00904813) | Karolinska Institutet | 1998-11-01 |
| ELRR by TEM Versus Laparoscopic TME in iT2N0M0 SMALL LOW RECTAL CANCER (NCT01609504) | University of Roma La Sapienza | 1997-04-01 |
| Spectroscopy With Surface Coils and Decoupling (NCT00581815) | Memorial Sloan Kettering Cancer Center | 1997-02-01 |
| Introduction and Influence of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer (NCT00910143) | Insel Gruppe AG, University Hospital Bern | 1993-01-01 |
| Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer (NCT01060501) | University of Ulm | 1992-07-01 |
| Does the Management of Anastomotic Leakage After Low Rectal Resection Affect Survival (NCT06059924) | Cantonal Hospital of St. Gallen | 1991-02-01 |
| TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer (NCT00137878) | GenVec | |